- Home
- AIRE vs HLVX Comparison
AIRE vs HLVX Comparison
Compare AIRE & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRE
- HLVX
- Stock Information
- Founded
- AIRE 2021
- HLVX 2020
- Country
- AIRE United States
- HLVX United States
- Employees
- AIRE N/A
- HLVX N/A
- Industry
- AIRE
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- AIRE
- HLVX Health Care
- Exchange
- AIRE Nasdaq
- HLVX Nasdaq
- Market Cap
- AIRE 86.1M
- HLVX 92.6M
- IPO Year
- AIRE N/A
- HLVX 2022
- Fundamental
- Price
- AIRE $1.84
- HLVX $1.83
- Analyst Decision
- AIRE Strong Buy
- HLVX Hold
- Analyst Count
- AIRE 1
- HLVX 5
- Target Price
- AIRE $3.00
- HLVX $2.33
- AVG Volume (30 Days)
- AIRE 288.5K
- HLVX 176.5K
- Earning Date
- AIRE 03-23-2025
- HLVX 03-19-2025
- Dividend Yield
- AIRE N/A
- HLVX N/A
- EPS Growth
- AIRE N/A
- HLVX N/A
- EPS
- AIRE N/A
- HLVX N/A
- Revenue
- AIRE $379,241.00
- HLVX N/A
- Revenue This Year
- AIRE $514.68
- HLVX N/A
- Revenue Next Year
- AIRE $129.41
- HLVX N/A
- P/E Ratio
- AIRE N/A
- HLVX N/A
- Revenue Growth
- AIRE 18.11
- HLVX N/A
- 52 Week Low
- AIRE $0.53
- HLVX $1.55
- 52 Week High
- AIRE $4.49
- HLVX $20.22
- Technical
- Relative Strength Index (RSI)
- AIRE 53.08
- HLVX 43.02
- Support Level
- AIRE $1.70
- HLVX $1.67
- Resistance Level
- AIRE $1.93
- HLVX $1.99
- Average True Range (ATR)
- AIRE 0.13
- HLVX 0.08
- MACD
- AIRE 0.02
- HLVX -0.00
- Stochastic Oscillator
- AIRE 68.42
- HLVX 48.48
About AIRE reAlpha Tech Corp.
ReAlpha Tech Corp is a real estate technology company that develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability; and has an app for investment into the properties that it purchased aimed at retail investors. The company's reportable segments are; Platform Services, which derives key revenue, and the Rental business segment.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.